Genome-Wide Association Studies in Plants
Genome-Wide Association Studies (GWAS) in plants are powerful tools used to identify genetic variants associated with specific traits by linking phenotypic data with genomic information. By analyzing large populations of diverse genotypes, researchers can pinpoint single nucleotide polymorphisms (SNPs) linked to traits like yield, disease resistance, and abiotic stress tolerance. GWAS has revolutionized plant breeding by facilitating marker-assisted selection, where breeders can use identified markers to select superior plants efficiently. This approach accelerates the development of improved varieties and enhances understanding of the genetic architecture underlying complex traits. GWAS continues to play a pivotal role in modern plant genomics and crop improvement strategies.
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States